PSRC Abstract Supplement
METHODS:
We obtained a cohort of craniosynostosis patients who underwent reconstruction between 2001 and 2017 using OptumInsight. Older age at surgery (>5 years), postoperative length of stay > 15 days, operative complications within 30 days of surgery, syndromic diagnoses, and cranial bone grafting merited exclusion. Our primary outcome was the use of post-operative CT scans. We used multilevel logistic regression to describe the odds of undergoing post-operative CTs, adjusting for patient and provider covariates.
RESULTS:
In this cohort (n=1,663), 448 patients (26.9%) underwent postoperative CTs, and the average number of post-operative CTs was 0.51 (range: 0-41). Intracranial hypertension (OR 1.82, p=0.044), older age at surgery (OR 1.35, p=0.001), increasing years of follow up (OR 1.12, p<0.001), and increasing comorbidities (OR 1.25, p=0.004) were associated with postoperative CTs. After adjusting for patient factors, provider factors still accounted for 30.5% of variation in imaging.
CONCLUSIONS:
Almost 30% of patients underwent CTs following reconstruction, and provider factors accounted for a large percentage of the variation. Given the risks of radiation, the frequency of CTs for routine follow up is concerning. Neurosurgeons and craniofacial surgeons face a critical need to establish post-operative imaging protocols to reduce unnecessary imaging in this vulnerable patient population. re-implant and repair lesions, the additional joint morbidity and costly in vitro expansion of primary chondrocytes limits widespread clinical application. Human bone marrow mesenchymal stem cells (hBMSCs) can be obtained by minimally invasive methods and could be a favorable source for cartilage regeneration. However, controlling the differentiation of BMSCs into the chondrocyte phenotype has hampered clinical implementation. The stimulation of human hBMSCs with xenogeneic chondrocytes has great potential for increasing the numbers of chondrogenic cells for cellular cartilage repair. The aim of this study was to determine the differentiation effects on human BMSCs and swine BMSc (sBMSc) by co-culture with swine chondrocytes or culture medium conditioned by chondrocytes.
METHODS:
Swine articular chondrocytes were isolated and grown in standard chondrocyte culture medium that was collected and used as chondrocyte-conditioned medium (CCM). hBMSCs and sBMSCs were expanded in normal bone marrow medium for 3 weeks and transferred to 6 well plates and Transwell plates for an additional one week. Then BMSCs cultured in 6-well plates were treated with CCM for 10 days. In the transwell cultures swine articular chondrocytes (sACs) were added in co-culture with the BMSCs for 10 days. Four different groups were performed: (1) hCCM, (2) hTranswell, (3) sCCM, (4) sTranswell. Real-time polymerase chain reaction was performed to evaluate the gene expression of collagen type II (COL2A1), and aggrecan (ACAN).
RESULTS:
After 10 days of culture, COL2A1 gene expression in hTranswell group was significantly increased 20-fold (p < 0.00001), compared with hCCM group, indicating that co-culture with chondrocytes had a greater effect on chondrogenic differentiation than the conditioned medium alone. ACAN expression in hTranswell group was significantly higher than hCCM group (p = 0.003), which further demonstrated that xenogeneic swine chondrocytes have a strong effect on chondrogenic differentiation of hBMSCs. ACAN gene expression in sTranswell group showed 30-fold greater than sCCM group (p = 0.00022), indicating this autologous co-culture model has potential to differentiate both hBMSC and sBMSC towards a chondrogenic phenotype.
CONCLUSION:
These results indicate that both xenogeneic co-culture models are capable differentiating hBMSC towards a chondrogenic phenotype. This approach could eliminate the need for autologous chondrocyte harvest by using a plentiful supply of xenogeneic chondrocytes to chondrodifferentiate a patient's own MSCs for cartilage repair. Recent development of alpha1,3-galactosyltransferase gene-knockout (GalT-KO) swine may even provide a source of xenogeneic MSCs that can be used in humans without the consequence of immune rejection. We hypothesized that incorporation of protocolized ICGinformed flap debridement at the time of surgery would decrease the incidence of fat necrosis.
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METHODS:
A single institution cohort study was performed evaluating patients before and after implementation of protocolized ICG-guided flap excision. Variables included demographics, procedural details, and complications. Multivariable analysis was used to determine significant differences between the cohorts and evaluate for meaningful changes in fat necrosis.
RESULTS: 80 patients were included, accounting for 137 flaps. Flap type was the only significant difference between the two groups with the ICG group more likely to be deep inferior epigastric perforator flaps, 43.1% vs. 25.3% p=0.038. The overall postoperative incidence of fat necrosis was 14.6 % (20 of 137 flaps). Comparing by cohort, the standard debridement group showed 18 of 79 flaps with fat necrosis (22.8%), while the ICG-informed debridement group showed only 2 of 58 flaps with fat necrosis (3.4%), odds ratio 0.11 (95% CI 0.02-0.60, p-value=0.011). There were no other significant differences in complication profile.
CONCLUSION:
Intraoperative use of indocyanine green angiography was associated with significantly lower odds of fat necrosis. This technology may reduce additional revisionary operations and improve patient satisfaction.
